Total Payments
$14,573
2024 Payments
$1,733
Companies
49
Transactions
696
Medicare Patients
1,760
Medicare Billing
$313,089
Payment Breakdown by Category
Food & Beverage$12,623 (86.6%)
Travel$1,593 (10.9%)
Education$326.82 (2.2%)
Consulting$30.03 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,623 | 680 | 86.6% |
| Travel and Lodging | $1,593 | 5 | 10.9% |
| Education | $326.82 | 9 | 2.2% |
| Consulting Fee | $30.03 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $2,591 | 106 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,833 | 119 | $0 (2024) |
| Apollo Endosurgery US Inc | $1,690 | 7 | $0 (2017) |
| ABBVIE INC. | $1,314 | 74 | $0 (2024) |
| Janssen Biotech, Inc. | $910.15 | 38 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $726.79 | 40 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $563.21 | 36 | $0 (2024) |
| QOL Medical, LLC | $526.01 | 30 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $419.53 | 23 | $0 (2022) |
| UCB, Inc. | $409.51 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,733 | 85 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($393.66) |
| 2023 | $1,872 | 108 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($276.54) |
| 2022 | $1,234 | 67 | Gilead Sciences, Inc. ($270.70) |
| 2021 | $1,777 | 93 | Gilead Sciences, Inc. ($408.67) |
| 2020 | $1,737 | 80 | Gilead Sciences, Inc. ($413.98) |
| 2019 | $1,466 | 84 | Gilead Sciences, Inc. ($411.95) |
| 2018 | $1,554 | 82 | Gilead Sciences, Inc. ($421.02) |
| 2017 | $3,199 | 97 | Apollo Endosurgery US Inc ($1,690) |
All Payment Transactions
696 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Immunology | ||||||
| 12/09/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.65 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $29.75 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Education | In-kind items and services | $39.56 | General |
| Category: LIVER DISEASE | ||||||
| 10/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: LIVER DISEASE | ||||||
| 09/30/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: GI COLON PREP | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 327 | 463 | $175,162 | $53,375 |
| 2022 | 9 | 409 | 558 | $231,857 | $68,497 |
| 2021 | 10 | 483 | 722 | $298,838 | $98,931 |
| 2020 | 12 | 541 | 878 | $311,139 | $92,286 |
Total Patients
1,760
Total Services
2,621
Medicare Billing
$313,089
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 182 | $38,766 | $15,488 | 40.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 46 | 48 | $48,000 | $11,975 | 24.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 20 | 21 | $21,000 | $6,782 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 110 | $15,942 | $6,546 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $17,405 | $4,234 | 24.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 12 | 12 | $12,000 | $3,831 | 31.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $11,000 | $2,209 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $7,449 | $1,623 | 21.8% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 11 | 12 | $3,600 | $686.29 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 205 | $43,732 | $16,579 | 37.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 54 | 57 | $57,000 | $14,442 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 124 | $17,484 | $8,146 | 46.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 27 | 28 | $28,000 | $7,928 | 28.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 22 | 22 | $33,000 | $7,720 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $22,074 | $5,775 | 26.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 18 | 18 | $18,000 | $5,711 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $10,887 | $2,088 | 19.2% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2022 | 11 | 14 | $1,680 | $109.08 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 365 | $77,745 | $33,933 | 43.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 77 | 77 | $77,000 | $21,143 | 27.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 33 | 33 | $33,000 | $10,868 | 32.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 24 | 26 | $39,000 | $9,347 | 24.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $25,046 | $7,204 | 28.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2021 | 16 | 16 | $16,000 | $5,267 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 78 | $10,998 | $5,013 | 45.6% |
About Dr. Ben Ogunwale, M.D
Dr. Ben Ogunwale, M.D is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720126600.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Ogunwale, M.D has received a total of $14,573 in payments from pharmaceutical and medical device companies, with $1,733 received in 2024. These payments were reported across 696 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,623).
As a Medicare-enrolled provider, Ogunwale has provided services to 1,760 Medicare beneficiaries, totaling 2,621 services with total Medicare billing of $313,089. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Charlotte, NC
- Active Since 02/02/2007
- Last Updated 03/16/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720126600
Products in Payments
- XIFAXAN (Drug) $1,151
- ORBERA (Device) $963.22
- STELARA (Biological) $804.14
- Orbera (Device) $726.90
- TRULANCE (Drug) $611.66
- Linzess (Drug) $546.36
- Epclusa (Drug) $474.58
- ZENPEP (Drug) $419.53
- Cimzia (Drug) $409.51
- DUPIXENT (Biological) $403.41
- Sucraid (Drug) $336.51
- Entyvio (Biological) $301.92
- IBSRELA (Drug) $290.88
- LINZESS (Drug) $285.07
- VOQUEZNA (Drug) $283.49
- Mavyret (Drug) $252.18
- GIVLAARI (Drug) $240.14
- HUMIRA (Biological) $232.48
- Vemlidy (Drug) $220.40
- SUCRAID (Drug) $189.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601